SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-003747
Accepted
2023-12-27 00:15:30
Documents
1
Effectiveness Date
2023-12-26
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 600
  Complete submission text file 9999999995-23-003747.txt   1749
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-276052 | Film No.: 231514509
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)